HIV prevention implant: patients and doctors share their hopes and concerns
NCT ID NCT05420207
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study interviewed 69 men who have sex with men (MSM) and their primary care doctors in Texas to understand their views on a future long-acting, implantable HIV prevention method (LA-PrEP). The goal was to identify what might help or hinder people from using such an implant and what training doctors would need. No actual implant was given; this was purely a research study to gather opinions and guide future development.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dell Medical School, UT-Austin
Austin, Texas, 78712, United States
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15261, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a conversation prevent HIV? study tests In-Person vs. online counseling for PrEP uptake
- Could a simple app help pharmacists stop HIV?
- New counseling approach aims to boost HIV prevention in young black men who have sex with men
- New HIV vaccine strategy aims to prime and boost immune defenses
- Can a standard HIV pill rescue those who got infected on Long-Acting PrEP?
- Can mailed HIV tests help prevent spread among drug users?